Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens

Vaccine

Volumn 33, Issue 38, 2015, Pages 5012-5019

  Laughlin, Richard C ^a   Mickum, Megan ^b   Rowin, Kristina ^b   Adams, L Garry ^a   Alaniz, Robert C ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Bacteria; Dendritic cell; Membrane vesicle; Vaccine platform

Indexed keywords

BACTERIAL ANTIGEN; INTERLEUKIN 12P40; SALMONELLOSIS VACCINE; TOLL LIKE RECEPTOR 4; BACTERIAL VACCINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL STRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEEDING; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOGENICITY; IN VITRO STUDY; INFLAMMATION; MEMBRANE VESICLE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; VACCINATION; ANIMAL; C3H MOUSE; IMMUNOLOGY; INNATE IMMUNITY; MEMBRANE MICROPARTICLE;

ANIMALS; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL-DERIVED MICROPARTICLES; DENDRITIC CELLS; FEMALE; IMMUNITY, INNATE; INFLAMMATION; MICE, INBRED C3H; SALMONELLA TYPHIMURIUM;

EID: 84940725197     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.05.014     Document Type: Article

References (50)

1. Jones K.E., Patel N.G., Levy M.A., Storeygard A., Balk D., Gittleman J.L., et al. Global trends in emerging infectious diseases. Nature 2008, 451(7181):990-993.
2. Bell B.G., Schellevis F., Stobberingh E., Goossens H., Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis 2014, 14:13.
3. Strikas R.A., Sinclair M.F., Morse S.A. Centers for disease control and prevention's bioterrorism preparedness program 2005, John Wiley & Sons, Inc.
4. Obiri N.I., Garçon N. Adjuvants-past, present, and future. The Jordan report: accelerated development of vaccines 2012 2012, 74-85. National Institute of Allergy and Infectious Diseases.
5. Curtiss R., Xin W., Li Y., Kong W., Wanda S.Y., Gunn B., et al. New technologies in using recombinant attenuated Salmonella vaccine vectors. Crit Rev Immunol 2010, 30(3):255-270.
6. Zhang S., Kingsley R.A., Santos R.L., Andrews-Polymenis H., Raffatellu M., Figueiredo J., et al. Molecular pathogenesis of Salmonella enterica serotype typhimurium-induced diarrhea. Infect Immun 2003, 71(1):1-12.
7. Santos R.L., Zhang S., Tsolis R.M., Kingsley R.A., Adams L.G., Baumler A.J. Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes Infect 2001, 3(14-15):1335-1344.
8. Dougan G., John V., Palmer S., Mastroeni P. Immunity to salmonellosis. Immunol Rev 2011, 240(1):196-210.
9. Wolfenden R.E., Layton S.L., Wolfenden A.D., Khatiwara A., Gaona-Ramirez G., Pumford N.R., et al. Development and evaluation of candidate recombinant Salmonella-vectored Salmonella vaccines. Poult Sci 2010, 89(11):2370-2379.
10. Laughlin R.C., Knodler L.A., Barhoumi R., Payne H.R., Wu J., Gomez G., et al. Spatial segregation of virulence gene expression during acute enteric infection with Salmonella enterica serovar Typhimurium. mBIO 2014, 5(1):e00913-e00946.
11. Fass E., Groisman E.A. Control of Salmonella pathogenicity island-2 gene expression. Curr Opin Microbiol 2009, 12(2):199-204.
12. Bijlsma J.J., Groisman E.A. The PhoP/PhoQ system controls the intramacrophage type three secretion system of Salmonella enterica. Mol Microbiol 2005, 57(1):85-96.
13. Ibarra J.A., Knodler L.A., Sturdevant D.E., Virtaneva K., Carmody A.B., Fischer E.R., et al. Induction of Salmonella pathogenicity island 1 under different growth conditions can affect Salmonella-host cell interactions in vitro. Microbiology 2010, 156(Pt 4):1120-1133.
14. Cameron A.D., Dorman C.J. A fundamental regulatory mechanism operating through OmpR and DNA topology controls expression of Salmonella pathogenicity islands SPI-1 and SPI-2. PLoS Genet 2012, 8(3):e1002615.
15. Dandekar T., Fieselmann A., Fischer E., Popp J., Hensel M., Noster J. Salmonella - how a metabolic generalist adopts an intracellular life style during infection. Front Cell Infect Microbiol 2014, 4(191).
16. Navarre W.W., Halsey T.A., Walthers D., Frye J., McClelland M., Potter J.L., et al. Co-regulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ. Mol Microbiol 2005, 56(2):492-508.
17. Brodsky I.E., Ernst R.K., Miller S.I., Falkow S. mig-14 is a Salmonella gene that plays a role in bacterial resistance to antimicrobial peptides. J Bacteriol 2002, 184(12):3203-3213.
18. Guo L., Lim K.B., Gunn J.S., Bainbridge B., Darveau R.P., Hackett M., et al. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 1997, 276(5310):250-253.
19. Delgado M.A., Mouslim C., Groisman E.A. The PmrA/PmrB and RcsC/YojN/RcsB systems control expression of the Salmonella O-antigen chain length determinant. Mol Microbiol 2006, 60(1):39-50.
20. Gunn J.S., Lim K.B., Krueger J., Kim K., Guo L., Hackett M., et al. PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol 1998, 27(6):1171-1182.
21. Tamayo R., Choudhury B., Septer A., Merighi M., Carlson R., Gunn J.S. Identification of cptA, a PmrA-regulated locus required for phosphoethanolamine modification of the Salmonella enterica serovar typhimurium lipopolysaccharide core. J Bacteriol 2005, 187(10):3391-3399.
22. Gentschev I., Dietrich G., Spreng S., Kolb-Maurer A., Brinkmann V., Grode L., et al. Recombinant attenuated bacteria for the delivery of subunit vaccines. Vaccine 2001, 19(17-19):2621-2628.
23. Dietrich G., Kolb-Maurer A., Spreng S., Schartl M., Goebel W., Gentschev I. Gram-positive and Gram-negative bacteria as carrier systems for DNA vaccines. Vaccine 2001, 19(17-19):2506-2512.
24. Beveridge T.J., Kadurugamuwa J.L. Periplasm, periplasmic spaces, and their relation to bacterial wall structure: novel secretion of selected periplasmic proteins from Pseudomonas aeruginosa. Microb Drug Resist 1996, 2(1):1-8.
25. Beveridge T.J. Structures of Gram-negative cell walls and their derived membrane vesicles. J Bacteriol 1999, 181(16):4725-4733.
26. Kuehn M.J., Kesty N.C. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev 2005, 19(22):2645-2655.
27. Mashburn-Warren L.M., Whiteley M. Special delivery: vesicle trafficking in prokaryotes. Mol Microbiol 2006, 61(4):839-846.
28. Hoekstra D., van der Laan J.W., de Leij L., Witholt B. Release of outer membrane fragments from normally growing Escherichia coli. Biochim Biophys Acta 1976, 455(3):889-899.
29. Katsui N., Tsuchido T., Hiramatsu R., Fujikawa S., Takano M., Shibasaki I. Heat-induced blebbing and vesiculation of the outer membrane of Escherichia coli. J Bacteriol 1982, 151(3):1523-1531.
30. Bergman M.A., Cummings L.A., Barrett S.L., Smith K.D., Lara J.C., Aderem A., et al. CD4+ T cells and toll-like receptors recognize Salmonella antigens expressed in bacterial surface organelles. Infect Immun 2005, 73(3):1350-1356.
31. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118(2):229-241.
32. Gordon M.A., Banda H.T., Gondwe M., Gordon S.B., Boeree M.J., Walsh A.L., et al. Non-typhoidal Salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 2002, 16(12):1633-1641.
33. Alaniz R.C., Deatherage B.L., Lara J.C., Cookson B.T. Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J Immunol 2007, 179(11):7692-7701.
34. Alaniz R.C., Cummings L.A., Bergman M.A., Rassoulian-Barrett S.L., Cookson B.T. Salmonella typhimurium coordinately regulates FliC location and reduces dendritic cell activation and antigen presentation to CD4+ T cells. J Immunol 2006, 177(6):3983-3993.
35. Garcia-del Portillo F., Stein M.A., Finlay B.B. Release of lipopolysaccharide from intracellular compartments containing Salmonella typhimurium to vesicles of the host epithelial cell. Infect Immun 1997, 65(1):24-34.
36. Muralinath M., Kuehn M.J., Roland K.L., Curtiss R. Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae. Infect Immun 2011, 79(2):887-894.
37. Deatherage B.L., Cookson B.T. Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life. Infect Immun 2012, 80(6):1948-1957.
38. McGregor A.C., Waddington C.S., Pollard A.J. Prospects for prevention of Salmonella infection in children through vaccination. Curr Opin Infect Dis 2013, 26(3):254-262.
39. Lawhon S.D., Khare S., Rossetti C.A., Everts R.E., Galindo C.L., Luciano S.A., et al. Role of SPI-1 secreted effectors in acute bovine response to Salmonella enterica Serovar Typhimurium: a systems biology analysis approach. PLoS ONE 2011, 6(11):e26869.
40. Miller S.I., Mekalanos J.J. Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages. J Bacteriol 1990, 172(5):2485-2490.
41. Barnes P.D., Bergman M.A., Mecsas J., Isberg R.R. Yersinia pseudotuberculosis disseminates directly from a replicating bacterial pool in the intestine. J Exp Med 2006, 203(6):1591-1601.
42. Maier T.M., Havig A., Casey M., Nano F.E., Frank D.W., Zahrt T.C. Construction and characterization of a highly efficient Francisella shuttle plasmid. Appl Environ Microbiol 2004, 70(12):7511-7519.
43. Chatfield S.N., Strahan K., Pickard D., Charles I.G., Hormaeche C.E., Dougan G. Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microb Pathog 1992, 12(2):145-151.
44. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282(5396):2085-2088.
45. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992, 176(6):1693-1702.
46. Badovinac V.P., Harty J.T. Intracellular staining for TNF and IFN-gamma detects different frequencies of antigen-specific CD8(+) T cells. J Immunol Methods 2000, 238(1-2):107-117.
47. Broadbent S.E., Davies M.R., van der Woude M.W. Phase variation controls expression of Salmonella lipopolysaccharide modification genes by a DNA methylation-dependent mechanism. Mol Microbiol 2010, 77(2):337-353.
48. Yan A., Guan Z., Raetz C.R. An undecaprenyl phosphate-aminoarabinose flippase required for polymyxin resistance in Escherichia coli. J Biol Chem 2007, 282(49):36077-36089.
49. Keiser P.B., Biggs-Cicatelli S., Moran E.E., Schmiel D.H., Pinto V.B., Burden R.E., et al. A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression. Vaccine 2011, 29(7):1413-1420.
50. Asensio C.J., Gaillard M.E., Moreno G., Bottero D., Zurita E., Rumbo M., et al. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate. Vaccine 2011, 29(8):1649-1656.